FAT1 gene alteration in facioscapulohumeral muscular dystrophy type 1

13Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is caused by contraction of the D4Z4 repeat array. Recent studies revealed that the FAT1 expression is associated with disease activity of FSHD, and the FAT1 alterations result in myopathy with a FSHD-like phenotype. We describe a 59-year-old woman with both contracted D4Z4 repeat units and a FAT1 mutation. Shoulder girdle muscle weakness developed at the age of 56 years, and was followed by proximal leg weakness. When we examined her at 59 years of age, she displayed asymmetric and predominant weakness of facial and proximal muscles. Muscle biopsy showed increased variation in fiber size and multifocal degenerating fibers with lymphocytic infiltration. Southern blot analysis revealed 8 D4Z4 repeat units, and targeted sequencing of modifier genes demonstrated the c.10331 A>G variant in the FAT1 gene. This FAT1 variant has previously been reported as pathogenic variant in a patient with FSHD-like phenotype. Our study is the first report of a FAT1 mutation in a FSHD1 patient, and suggests that FAT1 alterations might work as a genetic modifier.

Cite

CITATION STYLE

APA

Park, H. J., Lee, W., Kim, S. H., Lee, J. H., Shin, H. Y., Kim, S. M., … Choi, Y. C. (2018). FAT1 gene alteration in facioscapulohumeral muscular dystrophy type 1. Yonsei Medical Journal, 59(2), 337–340. https://doi.org/10.3349/ymj.2018.59.2.337

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free